e-learning
resources
London 2016
Monday, 05.09.2016
ILD pathogenesis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study
Karina Portillo Carroz (Barcelona, Spain), Karina Portillo Carroz, Iñaki Salvador-Corres, Eva Martinez -Cáceres, Carmen Centeno-Clemente, Aina Teniente-Serra, Juan Ruiz -Manzano, Alejandro Olivé-Marques
Source:
International Congress 2016 – ILD pathogenesis
Session:
ILD pathogenesis
Session type:
Poster Discussion
Number:
3102
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Karina Portillo Carroz (Barcelona, Spain), Karina Portillo Carroz, Iñaki Salvador-Corres, Eva Martinez -Cáceres, Carmen Centeno-Clemente, Aina Teniente-Serra, Juan Ruiz -Manzano, Alejandro Olivé-Marques. Usefulness of anti-Ro52 antibodies in the BAL of the patients with ILDs. Pilot study. Eur Respir J 2016; 48: Suppl. 60, 3102
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Panel discussion on genetics in pulmonary fibrosis
The new challenge of CTD-ILD: from basic science to clinical setting
Related content which might interest you:
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014
Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Bronchoalveolar lavage for the evaluation of interstitial lung disease: is it clinically useful?
Source: Eur Respir J 2011; 38: 761-769
Year: 2011
Clinical and immunological parameters in patients with newly diagnosed sarcoidosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease III
Year: 2013
Can IL-4Ralpha and PAR-2 in bronchoalveolar lavage fluid serve as biomarker of fibroproliferative healing in interstitial lung diseases?
Source: International Congress 2015 – New insights into IIPs
Year: 2015
Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006
The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Utility of bronchoalveolar lavage in vasculitis patients
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Retrospective assessment of pulmonary sarcoidosis with the aid of bronchoalveolar lavage (BAL) during the past three-year period in a general hospital
Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis
Year: 2013
Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016
Clinical significance of hemosiderin-laden macrophages in bronchoalveolar lavage fluid of patients with idiopathic interstitial pneumonias
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Indication of whole lung lavage in pulmonary alveolar proteinosis – Retrospective study
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Characterization of inflammation in bronchoalveolar lavage of lung transplant patients
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Usefulness of bronchoalveolar lavage in the diagnosis of desquamative interstitial pneumonia
Source: International Congress 2014 – ILDs 2
Year: 2014
Differences in the lipidomic profile of bronchial washing (BW) and bronchoalveolar lavage (BAL) in lung transplanted patients
Source: International Congress 2016 – Post-transplant complications: from animal models to the bedside
Year: 2016
Bronchoalveolar galactomannan in invasive pulmonary aspergillosis: A prospective study in pediatric patients
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
Lung involvement in multiple myeloma - study case
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Bronchoalveolar lavage fluid cytokines in the assessment of interstitial lung disease in systemic sclerosis: a prospective study
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Eosinophilic lung disease
Source: International Congress 2016 – Orphan diseases I
Year: 2016
Bronchoalveolar lavage in patients with fibrotic ILDs: is it helpful?
Source: International Congress 2019 – PG5 Novel insights into the diagnostic algorithm for interstitial lung diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept